August 5, 2008 at 10:27 am · Filed under Medical News, Hypertension
The Medicines Company (NASDAQ: MDCO) announced that the U.S. Food and Drug Administration (FDA) has approved the intravenous (IV) therapy CleviprexTM (clevidipine butyrate) injectable emulsion for the reduction of blood pressure when oral therapy is not feasible or not desirable.
Read the rest of this entry »
August 5, 2008 at 8:46 am · Filed under Medical News, Hypertension
The US Food and Drug Administration (FDA) has approved two single-pill combination medications, Diovan HCT(R) (valsartan and hydrochlorothiazide) and Exforge(R) (amlodipine and valsartan), as initial or ‘first-line’ therapies in patients likely to need multiple drugs to achieve their blood pressure goals.
Read the rest of this entry »
